María Tuñón

Prof. María Tuñón

Institute of Biomedicine (IBIOMED), University of León, and CIBER de Enfermedades Hepáticas y Digestivas, Spain
orcid

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2007 in European Journal of Pharmacology
Verified
Journal Article
Closed access
MGM. Victoria García-Mediavilla
M. Victoria García-Mediavilla
ICIrene Crespo
Irene Crespo
PCPilar S Collado
Pilar S Collado
AEAlejandro Esteller
Alejandro Esteller
SSSonia Sánchez-Campos
Sonia Sánchez-Campos
JGJavier González-Gallego
Javier González-Gallego

22 May 2018 in Experimental & Molecular Medicine
Verified
Journal Article
Open access
PDF file
Pedro EstevesPedro Esteves
Pedro Esteves
JAJoana Abrantes
Joana Abrantes
HBHanna-Mari Baldauf
Hanna-Mari Baldauf
LBLbachir BenMohamed
Lbachir BenMohamed
YCYuxing Chen
Yuxing Chen
RMRose Mage
Rose Mage
Studies using the European rabbit Oryctolagus cuniculus contributed to elucidating numerous fundamental aspects of antibody structure and diversification mechanisms and continue to be valuable for the development and testing of therapeutic humanized polyclonal and monoclonal antibodies. Additionally, during the last two decades, the use of the European rabbit as an animal model has been increasingly extended to many human diseases. This review documents the continuing wide utility of the rabbit as a reliable disease model for development of therapeutics and vaccines and studies of the cellular and molecular mechanisms underlying many human diseases. Examples include syphilis, tuberculosis, HIV-AIDS, acute hepatic failure and diseases caused by noroviruses, ocular herpes, and papillomaviruses. The use of rabbits for vaccine development studies, which began with Louis Pasteur’s rabies vaccine in 1881, continues today with targets that include the potentially blinding HSV-1 virus infection and HIV-AIDS. Additionally, two highly fatal viral diseases, rabbit hemorrhagic disease and myxomatosis, affect the European rabbit and provide unique models to understand co-evolution between a vertebrate host and viral pathogens.

1 March 2009 in Current Drug Metabolism
Verified
Journal Article
Closed access
MTMaría Tuñón
María Tuñón
MGM. Garcia-Mediavilla
M. Garcia-Mediavilla
SSSonia Sánchez-Campos
Sonia Sánchez-Campos
JGJ. Gonzalez-Gallego
J. Gonzalez-Gallego
Flavonoids are a large class of naturally occurring compounds widely present in fruits, vegetables, and beverages derived from plants. Reports have suggested that these compounds might be useful for the prevention of a number of diseases, partly due to their antiinflammatory properties. It has been demonstrated that flavonoids are able to inhibit expression of isoforms of inducible nitric oxide synthase, ciclooxygenase and lipooxygenase, which are responsible for the production of a great amount of nitric oxide, prostanoids and leukotrienes, as well as other mediators of the inflammatory process such as cytokines, chemokines or adhesion molecules. Modulation of the cascade of molecular events leading to the over-expression of those mediators include inhibition of transcription factors such as nuclear factor kappa B, activator protein 1, signal transducers and activators of transcription, CCAAT/enhancer binding protein and others. Effects on the binding capacity of transcription factors may be regulated through the inhibition of protein kinases involved in signal transduction, such as mitogen activated protein kinases. Although the numerous studies published with in vitro approaches allow identifying molecular mechanisms of flavonoid effects, the limited bioavailability of these molecules makes necessary validation in humans. Whatever the case, the data available make clear the potential utility of dietary flavonoids or new flavonoid-based agents for the possible treatment of inflammatory diseases. The present review summarizes recent research data focusing on the modulation of the expression of different inflammatory mediators by flavonoids and the effects on cell signaling pathways responsible for their anti-inflammatory activity.

1 January 2009 in World Journal of Gastroenterology
Verified
Journal Article
Open access
MTMaría Tuñón
María Tuñón
MAMarcelino Alvarez
Marcelino Alvarez
JCJesús M Culebras
Jesús M Culebras
JGJavier González-Gallego
Javier González-Gallego
An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure

1 October 2012 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
EMEder Marcolin
Eder Marcolin
BSBeatriz San-Miguel
Beatriz San-Miguel
DVDaniela Vallejo
Daniela Vallejo
JTJuliana Tieppo
Juliana Tieppo
NMNorma Marroni
Norma Marroni
MTMaría Tuñón
María Tuñón
We investigated whether quercetin protects from steatosis and limits the expression of proinflammatory and fibrogenic genes in C57BL/6J mice with non

1 November 2008 in British Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
ICIrene Crespo
Irene Crespo
MGM. Victoria García-Mediavilla
M. Victoria García-Mediavilla
BGBelén Gutiérrez
Belén Gutiérrez
SSSonia Sánchez-Campos
Sonia Sánchez-Campos
MTMaría Tuñón
María Tuñón
JGJavier González-Gallego
Javier González-Gallego
We investigated the effects of the flavonols kaempferol and quercetin on the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), endothelial cell selectin (E-selectin), inducible NO synthase (iNOS) and cyclo-oxygenase-2 (COX-2), and on the activation of the signalling molecules NF-κB and activator protein-1 (AP-1), induced by a cytokine mixture in cultured human umbilical vein endothelial cells. Inhibition of reactive oxygen and nitrogen species generation did not differ among both flavonols at 1 μmol/l but was significantly stronger for kaempferol at 5–50 μmol/l. Supplementation with increasing concentrations of kaempferol substantially attenuated the increase induced by the cytokine mixture in VCAM-1 (10–50 μmol/l), ICAM-1 (50 μmol/l) and E-selectin (5–50 μmol/l) expression. A significantly inhibitory effect of quercetin on VCAM-1 (10–50 μmol/l), ICAM-1 (50 μmol/l) and E-selectin (50 μmol/l) expression was also observed. Expression of adhesion molecules was always more strongly inhibited in kaempferol-treated than in quercetin-treated cells. The inhibitory effect on iNOS and COX-2 protein level was stronger for quercetin at 5–50 μmol/l. The effect of kaempferol on NF-κB and AP-1 binding activity was weaker at high concentrations (50 μmol/l) as compared with quercetin. The present study indicates that differences exist in the modulation of pro-inflammatory genes and in the blockade of NF-κB and AP-1 by kaempferol and quercetin. The minor structural differences between both flavonols determine differences in their anti-inflammatory properties and in their efficiency in inhibiting signalling molecules.